Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Abiomed Inc., consolidated statement of comprehensive income

US$ in thousands

12 months ended:	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Net income	136,505)	225,525)	203,009)	259,016)	112,170)	52,116)
Foreign currency translation gains (losses)	(5,844)	2,142)	(1,832)	(11,431)	16,862)	(5,855)
Unrealized gains (losses) on derivative instrument	(1,779)	(2,095)	3,999)	—)	—)	—)
Net unrealized gains (losses) on marketable securities, net of tax	(8,092)	(303)	1,333)	946)	(460)	(211)
Other comprehensive income (loss)	(15,715)	(256)	3,500)	(10,485)	16,402)	(6,066)
Comprehensive income	120,790)	225,269)	206,509)	248,531)	128,572)	46,050)

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Download chart

Comprehensive income item	Description	The company
Net income	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Abiomed Inc. net income increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.
Comprehensive income	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners.	Abiomed Inc. comprehensive income increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.

Abiomed Inc. (NASDAQ:ABMD)

Statement of Comprehensive Income